Inspire Medical Systems
INSP
55.10
-1.18
-2.10%
Inspire Medical Systems
US · INSP
#2781 by market cap
Listed 2018
55.10
-1.18
-2.10%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions increased by 22 in the most recent period (2026/Q3).
- Total institutional ownership fell 1.7 percentage points.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 128.92% -1.73pp
- Institutions
- 347 +22
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund75.30%
Hedge Fund33.59%
Public Company11.39%
Private Company5.50%
Government Pension Fund2.00%
Individual/Insider1.27%
Sovereign Wealth Fund0.68%
Insurance Company0.31%
Top holders as of 2026-09-30
BlackRock
16.06% · 4.65M sh
UBS Asset Management
8.28% · 2.40M sh
Wellington Management Group
8.23% · 2.38M sh
AQR Capital Management
6.40% · 1.85M sh
Soleus Capital Management, L.P.
6.68% · 1.93M sh
Vanguard Portfolio Management, LLC
5.88% · 1.70M sh
D. E. Shaw & Co., L.P.
5.08% · 1.47M sh
Nomura Holdings, Inc.
4.73% · 1.37M sh
Deerfield Management Company, L.P.
4.48% · 1.30M sh
Vanguard Capital Management, LLC
4.40% · 1.27M sh
State Street Global Advisors
4.32% · 1.25M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 32 buys · 17 sells
| Name | Role | Stake |
|---|---|---|
| Timothy Herbert | Chairperson & CEO | 0.71% |
| Richard Buchholz | Former Financial Advisor | 0.14% |
| Shawn McCormick | Independent Director | 0.09% |
| Casey Tansey | Former Independent Director | 0.08% |
| Dana Mead | Independent Director | 0.07% |
| Bryan Phillips | Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary | 0.03% |
| Gary Ellis | Lead Independent Director | 0.03% |
| John Rondoni | Former Chief Technology Officer | 0.02% |
| Michael Carrel | Director | 0.02% |
| Shelley Broader | Independent Director | 0.02% |
| Georgia Garinois-Melenikiotou | Independent Director | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-13 | Michael Carrel | Director | Other Acquisition | +203 | $68.07 |
| 2026-10-13 | Shelley Broader | Independent Director | Other Acquisition | +284 | $68.07 |
| 2026-10-13 | Gary Ellis | Lead Independent Director | Other Acquisition | +431 | $68.07 |
| 2026-10-13 | Georgia Garinois-Melenikiotou | Independent Director | Other Acquisition | +255 | $68.07 |
| 2026-08-30 | Jason Kelly | Chief Operations & Innovation Officer | Other Acquisition | +6,350 | -- |
| 2026-08-06 | Jason Kelly | Chief Operations & Innovation Officer | Open Market Disposition | -963 | $59.55 |
| 2026-07-30 | Melissa Mann | Chief Human Resources Officer | Sale to Issuer | -652 | $50.21–124.54 |
| 2026-07-19 | Michael Carrel | Director | Other Acquisition | +5,631 | -- |
| 2026-07-14 | Casey Tansey | Former Independent Director | Other Acquisition | +346 | -- |
| 2026-07-14 | Shelley Broader | Independent Director | Other Acquisition | +383 | -- |
| 2026-07-14 | Gary Ellis | Lead Independent Director | Other Acquisition | +581 | -- |
| 2026-07-14 | Georgia Garinois-Melenikiotou | Independent Director | Other Acquisition | +344 | -- |
| 2026-05-14 | John Rondoni | Former Chief Technology Officer | Open Market Disposition | -2,641 | $43.28 |
| 2026-05-13 | John Rondoni | Former Chief Technology Officer | Open Market Disposition | -700 | $43.01 |
| 2026-05-07 | Shawn McCormick | Independent Director | Open Market Disposition | -696 | $45.31 |
| 2026-04-30 | Georgia Garinois-Melenikiotou | Independent Director | Sale to Issuer | -50 | $56.70 |
| 2026-04-29 | Casey Tansey | Former Independent Director | Other Acquisition | +3,562 | -- |
| 2026-04-29 | Dana Mead | Independent Director | Other Acquisition | +3,562 | -- |
| 2026-04-29 | Shawn McCormick | Independent Director | Other Acquisition | +3,562 | -- |
| 2026-04-29 | Shelley Broader | Independent Director | Other Acquisition | +3,562 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Inspire Medical Systems discussion 0 comments